Literature DB >> 15754160

Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention.

Waleed Ajaj1, Mathias Goyen, Hubert Schneemann, Christiane Kuehle, Michael Nuefer, Stefan G Ruehm, Susanne C Goehde, Thomas C Lauenstein.   

Abstract

To assess the effect of the osmolarity for small bowel distension in MRI, ten volunteers ingested at two separate occasions negative oral contrast agents with different quantity and osmolarity: (1) a water solution combined with 2.0% sorbitol and 0.2% locus bean gum (LBG) with a quantity of 1500 ml and an osmolarity of 148 mOsmol/l, (2) a water solution combined with 2.0% sorbitol and 2.0% barium sulphate with a quantity of 1000 ml and an osmolarity of 194 mOsmol/l. Small bowel distension was quantified on coronal 2D-TrueFISP images by measuring the small bowel diameters. There were no statistically significant differences in mean small bowel diameter between both contrast agents. The mean small bowel distension was 19.2 mm after ingestion of 1500 ml of sorbitol-LBG solution and 19.0 mm after ingestion of 1000-ml sorbitol-barium sulphate solution. Furthermore, all volunteers found the ingestion of 1000-ml solution more pleasant than the 1500-ml solution. The ingestion of 1000 ml of sorbitol-barium sulphate solution led to a sufficient small bowel distension compared to 1500 ml of sorbitol-LBG solution. The side effect rate of both solutions was low. Based on these data, we recommend a quantity of 1000 ml of sorbitol-barium sulphate solution as an alternative for 1500-ml sorbitol-LBG solution for optimal bowel distension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754160     DOI: 10.1007/s00330-005-2711-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Small bowel MRI using water as a contrast medium.

Authors:  D J Lomas; M J Graves
Journal:  Br J Radiol       Date:  1999-10       Impact factor: 3.039

2.  MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences.

Authors:  N Gourtsoyiannis; N Papanikolaou; J Grammatikakis; T Maris; P Prassopoulos
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

3.  MR enteroclysis: technical considerations and clinical applications.

Authors:  Nicholas Gourtsoyiannis; Nickolas Papanikolaou; John Grammatikakis; Panos Prassopoulos
Journal:  Eur Radiol       Date:  2002-06-04       Impact factor: 5.315

4.  Bowel MR imaging with oral Gastrografin: an experimental study with healthy volunteers.

Authors:  A S Borthne; J B Dormagen; K I Gjesdal; T Storaas; I Lygren; J T Geitung
Journal:  Eur Radiol       Date:  2002-07-02       Impact factor: 5.315

5.  Combined small and large bowel MR imaging in patients with Crohn's disease: a feasibility study.

Authors:  Burcu Narin; Waleed Ajaj; Susanne Göhde; Jost Langhorst; Haldun Akgöz; Guido Gerken; Stefan G Rühm; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2004-06-18       Impact factor: 5.315

6.  Crohn disease of the small intestine: accuracy and relevance of enteroclysis.

Authors:  D D Maglinte; S M Chernish; F M Kelvin; K W O'Connor; J P Hage
Journal:  Radiology       Date:  1992-08       Impact factor: 11.105

Review 7.  The epidemiology and the pathogenesis of inflammatory bowel disease.

Authors:  K Karlinger; T Györke; E Makö; A Mester; Z Tarján
Journal:  Eur J Radiol       Date:  2000-09       Impact factor: 3.528

8.  Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation.

Authors:  U Kettritz; K Isaacs; D M Warshauer; R C Semelka
Journal:  J Clin Gastroenterol       Date:  1995-10       Impact factor: 3.062

9.  Detection of surgical lesions of the small bowel by enteroclysis.

Authors:  D D Maglinte; R Hall; R E Miller; S M Chernish; B Rosenak; M Elmore; B T Burney
Journal:  Am J Surg       Date:  1984-02       Impact factor: 2.565

10.  Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension.

Authors:  Waleed Ajaj; Susanne C Goehde; Hubert Schneemann; Stefan G Ruehm; Jörg F Debatin; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2003-11-22       Impact factor: 5.315

View more
  19 in total

1.  MR motility imaging in Crohn's disease improves lesion detection compared with standard MR imaging.

Authors:  Johannes M Froehlich; Christian Waldherr; Christoforos Stoupis; S Mehmet Erturk; Michael A Patak
Journal:  Eur Radiol       Date:  2010-04-09       Impact factor: 5.315

2.  Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging.

Authors:  Arne S Borthne; Michael Abdelnoor; Trygve Storaas; Claude Pierre-Jerome; Nils-E Kløw
Journal:  Eur Radiol       Date:  2006-02-21       Impact factor: 5.315

3.  A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis.

Authors:  Anne Negaard; Vemund Paulsen; Leiv Sandvik; Audun Elnaes Berstad; Arne Borthne; Kirsti Try; Idar Lygren; Tryggve Storaas; Nils-Einar Klow
Journal:  Eur Radiol       Date:  2007-05-05       Impact factor: 5.315

Review 4.  Updating magnetic resonance imaging of small bowel: imaging protocols and clinical indications.

Authors:  Jiong Zhu; Jian-Rong Xu; Hong-Xia Gong; Yan Zhou
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

5.  Comparison of 3% sorbitol vs psyllium fibre as oral contrast agents in MR enterography.

Authors:  Sidharth Saini; Errol Colak; Shalini Anthwal; Paraskevi A Vlachou; Antony Raikhlin; Anish Kirpalani
Journal:  Br J Radiol       Date:  2014-07-25       Impact factor: 3.039

6.  Comparison of three oral contrast preparations for magnetic resonance enterography in pediatric patients with known or suspected Crohn disease: a prospective randomized trial.

Authors:  Ravi V Gottumukkala; Annette LaPointe; Donna Sargent; Michael S Gee
Journal:  Pediatr Radiol       Date:  2019-03-09

Review 7.  [Radiological characterization of chronic inflammatory bowel disease].

Authors:  H Schöllnast
Journal:  Radiologe       Date:  2018-04       Impact factor: 0.635

Review 8.  Magnetic resonance imaging in children and adolescents with chronic inflammatory bowel disease.

Authors:  Hans-Joachim Mentzel; Steffen Reinsch; Monika Kurzai; Martin Stenzel
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

9.  Diagnostic performance of MRI for detection of intestinal fistulas in patients with complicated inflammatory bowel conditions.

Authors:  S Schmidt; P Chevallier; B Bessoud; J-Y Meuwly; C Felley; R Meuli; P Schnyder; A Denys
Journal:  Eur Radiol       Date:  2007-05-10       Impact factor: 5.315

10.  Value of cine MRI for better visualization of the proximal small bowel in normal individuals.

Authors:  Michael R Torkzad; Roberto Vargas; Chikako Tanaka; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2007-07-28       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.